GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 88 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $795,000 | -77.6% | 82,589 | -72.5% | 0.02% | -79.4% |
Q2 2017 | $3,555,000 | -65.4% | 300,493 | -62.5% | 0.10% | -76.0% |
Q1 2017 | $10,280,000 | +4.7% | 801,865 | 0.0% | 0.42% | -19.5% |
Q4 2016 | $9,815,000 | +3.7% | 801,865 | 0.0% | 0.53% | +2.7% |
Q3 2016 | $9,462,000 | -6.3% | 801,865 | -30.9% | 0.51% | -2.7% |
Q2 2016 | $10,096,000 | +65.1% | 1,160,430 | 0.0% | 0.53% | +32.7% |
Q1 2016 | $6,115,000 | -32.1% | 1,160,430 | 0.0% | 0.40% | -4.1% |
Q4 2015 | $9,005,000 | +6.1% | 1,160,430 | +7.6% | 0.42% | -26.3% |
Q3 2015 | $8,485,000 | -12.5% | 1,078,127 | +0.7% | 0.56% | -10.9% |
Q2 2015 | $9,697,000 | -29.5% | 1,070,340 | +0.9% | 0.63% | -23.8% |
Q1 2015 | $13,764,000 | -3.9% | 1,060,385 | +0.8% | 0.83% | -4.9% |
Q4 2014 | $14,317,000 | +54.6% | 1,051,933 | +1.9% | 0.87% | +54.1% |
Q3 2014 | $9,260,000 | -33.7% | 1,032,370 | +0.0% | 0.57% | -35.9% |
Q2 2014 | $13,968,000 | +42.0% | 1,032,369 | +4.3% | 0.88% | +30.4% |
Q1 2014 | $9,836,000 | -22.5% | 989,571 | +3.7% | 0.68% | -23.0% |
Q4 2013 | $12,686,000 | +4.7% | 954,560 | -4.3% | 0.88% | +1.0% |
Q3 2013 | $12,112,000 | +24.6% | 997,676 | +6.2% | 0.87% | +18.0% |
Q2 2013 | $9,720,000 | – | 939,265 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|